7.96 USD
↘ 0.45 (5.30%)LIVE (AS OF 12:06 PM EDT)
Alumis Inc. Common Stock
ALMSNASDAQ • USD
Market: OPEN
Shares of Alumis Inc. Common Stock (ALMS) are trading at $7.96. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ALMS at a fair price relative to peers.
Technical & fundamental data as of Sep 15, 2026.
Open?$8.45
High?$8.45
Low?$7.94
Prev. Close?$8.40
Volume?1.3M
Avg. Volume?3.0M
VWAP?$8.11
Rel. Volume?0.42x
Bid / Ask
Bid?$7.93 × 200
Ask?$7.96 × 100
Spread?$0.03
Midpoint?$7.95
Valuation & Ratios
Market Cap?1.1B
Shares Out?129.4M
Float?74.5M
Float %?60.4%
P/E Ratio?N/A
P/B Ratio?2.40
EPS?-$3.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Themes
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?19
Momentum?10
Short Sent.?54
Piotroski F-Score?1/9Weak
Altman Z-Score?1.42Distress
Confidence?63%Moderate
Short InterestHigh
Short % of Float?7.58%Elevated
Short Interest?5.6M
Days to Cover?7.1
Free Float74.5M
Avg Daily Volume799.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?6.74Strong
Quick Ratio?6.74Strong
Cash Ratio?0.84Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.40CHEAP▾
Peers100
S&P66
P/S?146.97HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.5CHEAP▾
S&P97
EV/Sales?138.35HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-97.1%WEAK▾
S&P3
ROA?-78.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-351799000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day